ABSTRACT
INTRODUCTION
Accurate and specific measurement of donor cell engraftment is pivotal in murine experimental transplantation studies (4, 11, 12, 18) . Despite limitations in their application to human stem cell research, murine models are not only used to evaluate novel candidate stem cell populations but also increasingly to study the impact of ex vivo manipulations on hematopoietic stem cells (HSCs) (11, 12) . The success of clinical HSC transplantation depends on the rate, level, and duration at which donor stem cells repopulate and reconstitute functional hematopoiesis in the recipient. Engraftment is determined by assessing the presence of specific markers on donor tissue, which allows discrimination from recipient tissue. Current assays suffer from distinct disadvantages that limit their usefulness, such as the restriction of the assay to certain strains, labor intensity, low sample throughput, the need to sacrifice the animal, and handling of hazardous material such as radioactivity (4,10-12, 17,18) Although one log-fold more sensitive than Southern analysis, semi-quantitative PCR methods are extremely labor intensive, and for this reason they have not replaced quantitative Southern analysis in murine engraftment studies (11, 12, 14, 20) .
Quantitative real-time PCR (kinetic PCR) has recently been introduced to simplify the accurate and specific quantification of target sequences (6, 15) . In a clinical application, kinetic PCR for the sex-determining region Y was found to be valuable for the quantification of male fetal cells in the maternal circulation (8) . Here, we describe kinetic PCR as an accurate and highly specific method to quantitate male DNA in female recipients with a 3-log fold increase in sensitivity over Southern analysis. An 81-nucleotide Y-chromosome sequence present as four copies per cell (zfy1 and zfy2) was selected to amplify male donor sequences admixed to female. Additional advantages of kinetic PCR are strain independence, no radioactivity, and the simplicity of the assay. The new assay allows the analysis of a greater number of samples without sample DNA concentration adjustment or subsequent gel electrophoresis. Engraftment kinetics can be established for individual animals using very small tissue samples, which may eliminate the need to sacrifice the animal. We believe this procedure significantly simplifies and economizes engraftment studies for murine experimental transplantation studies.
Animals
Female and male C57Bl/6, BALB/C, and CHB mice ages 4-5 weeks (Charles River Laboratories, Wilmington, MA, USA) were used in the experiments and housed in the Louisiana State University Health Sciences Center animal care facility. Blood was collected from anesthetized mice in sterile heparinized tubes by retroorbital puncture. The red blood cells were lysed, and the samples were processed for DNA extraction.
DNA Isolation
Samples consisting of 40 µ L peripheral blood (approximately 5 × 10 5 cells) were resuspended in 40 µ L PBS. DNA was isolated using a blood DNA extraction kit (QIAamp ® DNA Blood Minikit; Qiagen, Valencia, CA, USA). To enhance the yield of eluted DNA, 200 µ L heated (42°C) AE buffer were applied to each sample column, followed by a 2-min incubation period before the final centrifugation step. Scaleup purification was performed to generate male or female DNA stock solutions. To increase the concentration of the DNA in the eluate, samples were subjected to ethanol precipitation in the presence of glycogen (13) , and the DNA pellets resuspended in 35 µ L distilled water were processed for analysis or stored at -20°C.
Quantification of Total DNA Concentration
DNA samples and standards were measured using the Hoechst 33258 Dye-Based Fluorescent DNA Quantitation kit (Bio-Rad Laboratories, Hercules, CA, USA), which utilizes the specific binding of the fluorescent dye Hoechst 33258 to dsDNA (5) . Sample or standard (4 µ L) DNA were analyzed according to the manufacturer's protocol, and the fluorescence was measured with a FL-600 Microplate Fluorescence Reader (BioTek, Winooski, VT, USA). The mean values of the standard readings were used to generate standard curves. The DNA concentration of each sample was determined from the standard curve.
Stock solutions of female and male DNA were prepared. Using limiting dilution, a series of standards with constant amounts of XY male DNA in a variable XX female DNA background (2.5-200 ng) were prepared in a defined template volume (4 µ L) for each reaction.
Amplification of Y Target Sequences with Kinetic PCR
Samples were assayed using TaqMan ® chemistry and kinetic PCR (ABI 5700 Sequence Detector; Applied Biosystems, Foster City, CA, USA).
The Y-chromosome-specific primer pair and fluorescent probe were designed using the Primer Express software (Applied Biosystems) and based on the zfy2 gene sequence (GenBank ® accession no. M24401) (9) . However, in the mouse genome, a 100% homologous sequence, zfy1 (accession no. NM009570), exists (3). Thus, there are four copies of target template per male cell. The sense (5 ′ -TGGAGAGCCA -CAAGCTAACCA-3 ′ ) and antisense (5 ′ -TCCCAGCATGA GAAAGATTC -TTC-3 ′ ) primers (Integrated DNA Technologies, Coralville, IA, USA) flank a 40-bp region of the target sequence and generate an 81-nucleotide product. The custom-made probe contains a 6-carboxyfluorescein (6FAM) reporter molecule and a 6-carboxy tetramethyl-rhodamine (TAMRA) quenching molecule, coupled to the 5 ′ and 3 ′ ends of the probe sequence (5 ′ -6FAM-CAGTCA TCACATTCGGTG-GTCTTT T CTGTCTTA-TAMRA-3 ′ ) (Applied Biosystems). The probe recognizes a 33-nucleotide segment within the product region on the antisense strand of the target sequence.
Samples and standards were amplified using the TaqMan ® PCR Core Reagent kit (Applied Biosystems) according to the manufacturer's protocol, except the concentrations of reagents were changed as follows: 7 mM MgCl 2 was used in the amplification reaction, with 300 nM sense primer, 900 nM antisense primer, and 100 nM TaqMan Three concentration values of blood-derived male DNA (0.01, 1.0, and 20.0 ng, complemented with female blood-derived DNA to achieve a total sample DNA quantity of 40 ng) were screened for the presence of zfy1/zfy2 target sequences. Analysis was conducted by kinetic PCR on four separate occasions over a two-week period. The mean results ± SEMof triplicate assays are presented for individual experiments and the mean ± SEMfor the series of experiments. The CV for each individual experiment (intra-assay) and the combination of the series of experiments (inter-assay) were also determined. Figure 1 . Detection of zfy1/zfy2 DNA. Samples of serially diluted murine male DNA obtained from peripheral blood were prepared in a background of female DNA and plotted as copy number (thick tick) or percent (thin tick) of the pre-amplification log value on the X-axis. A curve was generated using regression analysis. The specificity of the assay was determined by comparing values obtained from the male/female DNA samples with the female controls (open squares). The double set of asterisks denotes that a significant level of difference ( P< 0.05) exists between the pre-amplification copy number of both data points. The single asterisk denotes that a significant level of difference ( P< 0.05) exists between the indicated pre-amplification copy number of zfy1/zfy2 and the female DNA control.
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probe. The master mixture was dispensed into the individual wells of the reaction plate. DNA sample or standard at 4 µ L/well was then added to achieve a final volume of 50 µ L. Samples and standards were set up in triplicate reactions using aerosol-resistant tips and optical-grade caps. Negative controls lacking AmpErase ™, AmpliTaq ® Gold DNA polymerase, or DNA template were included in the reaction series and assembled first and then sealed with optical-grade caps before setting up the other reactions. The DNA samples and standards were amplified according to default conditions with the following modifications: two heating/cooling cycles (95°C for 1.5 min and 55°C for 2 min) were added following the AmpErase incubation step.
The Taq activation step was shortened to 6 min at 95°C, and an annealing step was added to the amplification process. An amplification reaction was then initiated for 45 cycles of 94°C for 15 s, 58°C for 20 s, and 60°C for 35 s.
Cycle threshold (Ct) readings from known XY/XX standard mixtures were utilized to establish standard curves for each reaction series. For each standard curve, the threshold baseline was adjusted individually, and only those reactions with slope values of -3.3 ± 0.1 and an R-coefficient greater than 0.990 were accepted for further analysis.
Data Analysis
The Ct number was computed for each sample using the Sequence Detection Software (Applied Biosytems). The Ct baseline was preset at 10 standard deviations above the fluorescence background, which was determined in the first 3-15 cycles. These settings were automatically used by the system for further computation. The standard curves were generated by plotting the mean of triplicate Ct values versus the log of the Y copy number and calculation of a regression line. The copy number for the unknown samples was determined by applying the mean Ct value of triplicates to the standard curve and corrected for the total amount of DNA in the sample to determine the percentage of male sequence within a female background. The statistical significances for sample differences were analyzed by using the Student's t test provided in a statistical software program (Sigma Plot ™; SPSS Science, Chicago, IL, USA). A P< 0.05 constituted the statistical significance.
RESULTS AND DISCUSSION
zfy1/zfy2 Kinetic PCR Amplifies Blood-Derived Male DNA at High Sensitivity
The goal of this study was to develop a quantitative real-time PCR assay that would be more sensitive than currently used assays, highly specific, and simple enough to permit the high throughput of samples derived from a small amount of blood or tissue. The amplification of a single gene or low copy number Y-chromosomal sequences, such as portions of the pY2 nucleotide sequence or that of the zfy2 Y gene, is considered to be more specific and accurate than the amplification of repetitive elements (4, 7, 16) . Therefore, for the development of the kinetic PCR assay, an amplification target sequence was selected that was present at four copies per male cell (zfy1 and zfy2).
Blood-derived DNA is the most difficult tissue for PCR, as several Taq DNA polymerase inhibitors are present (1,2). Consistent and reproducible amplification for blood-derived samples could not be accomplished with template DNA obtained by standard extraction (data not shown). The DNA extraction protocol outlined in the Ma - terials and Methods section utilizes commercially available Qiagen kits. This method provided blood-derived DNA with amplification kinetics comparable to bone marrow and other tissues (data not shown). The previously described glycogen DNA concentration step was found to be useful specifically for small sample sizes and was therefore added to the manufacturer's protocol (30-50 µ L blood/sample) (13). Using the methodology described here, small blood samples (30-50 µ L) are sufficient to accurately determine Y chromosome copy number. In contrast, the removal of TaqDNA polymerase inhibitors is not required for non-blood-derived tissue. Thus, kinetic PCR analysis can be performed directly on tissue samples with less than 500 cells, and DNA consumption during purification is not a problem (data not shown).
To demonstrate specific and quantitative amplification of the Y chromosome sequence in blood samples, dilutions of XY-derived DNA were admixed to XX DNA and amplified using the conditions described above. XY sequences could be detected with a sensitivity of 2.2 ×10 -2 % (six copies of Y target DNA in 40 ng XX DNA background or 1.5 male cells in 6667 female cells) ( P< 0.0005). Amplification was logarithmic throughout the entire concentration range up to 100% of XY (replacement of XX background DNA with XY DNA). Six consecutive amplifications produced nearly identical line equations with regression analysis applied (no statistical difference), and the mean R 2 value for the reaction series was greater than 0.99. Differences in XY quantity could be detected for 0.5 log DNA amount ( P< 0.005). No signal was detected at any sample concentration for female DNA only (Figure 1) . No difference was seen if XY DNA from different mouse strains (C57BL6, BALB/C, and CHB) was amplified, which concludes that the assay is strain independent (data not shown).
In comparison to Southern analysis, kinetic PCR increased sensitivity by over 1 log-fold. Kinetic PCR also accurately distinguished 0.5 log-fold quantitative differences in template DNA over the entire range of ratios examined. Compared to Southern analysis, kinetic PCR is free of any radioactivity, and the entire analysis including DNA extraction can be completed in one day. Additional studies similar to those previously described by Zhang et al. (19) were performed using β -globin as the amplification control to compensate for differences in the amplificability of blood-derived DNA. However, we found that this additional step did not add significantly to the reliability of the assay (data not shown).
Kinetic PCR Specifically and Reliably Amplifies zfy1/zfy2
Sequences within a 20-Fold Range of Total Starting DNA Most DNA-based assays require cumbersome adjustment and equalizing of each individual sample for the total amount of starting DNA, in the way of at least one additional pipetting step.
To test whether kinetic PCR could accurately detect Y chromosome copies within a given range of total starting DNA, samples with identical amounts of male DNA were analyzed in different backgrounds of female DNA. The total DNA ranged from 2.5 to 200 ng/sample (80-fold difference). Standards were established by adjusting the total amount of DNA per standard point to 40 ng/sample, and all samples were analyzed at the same time. Robust and overlapping logarithmic amplification curves were found for DNA starting quantities of 2.5-50 ng/sample with the standard curve (Figure 2) . Thus, the accurate determination of Y copy number can be accomplished over a 20-fold range of total DNA per sample. In practical terms, this means that samples could be prepared from a large group of animals directly for kinetic PCR analysis by simply choosing the expected medium DNA amount per sample. The exact DNA concentration is determined separately on 96-well plates for the final calculation of chimerism percentage. In case of potential outliers, these would be identified and could be analyzed in a second reaction after adjustment of the DNA concentration.
Therefore, compared to conventional PCR/semi-quantitative PCR, kinetic PCR simplifies the setup and conduct by eliminating two laborious steps. First, the procedure no longer requires the ad -justment of the total DNA for each individual sample, as the kinetic PCR can accurately determine zfy1/zfy2-sequences over a 20-fold range of total starting DNA. This feature allows the hematologist to directly process the extracted DNA for PCR analysis from a large group of animals. The zfy1/zfy2 copy numbers are later adjusted for the total DNA per sample to calculate the actual percentage of male DNA. Second, no post-reaction procedure is required to resolve and quantitate amplification products, as results (zfy1/zfy2 copy number/sample) are available immediately upon conclusion of the reaction.
Kinetic PCR Accurately Determines Y Copy Number in a Blinded Study
Samples with known ratios of male/ female DNA (0.25%-100% of total DNA) were prepared with the total amount of DNA being kept within the range of 2.5-50 ng/sample. The samples were analyzed by a second individual in a blinded fashion, and results were determined from the standard curves. Data points of the analysis were overlaid with the actual Y copy number, and Figure 3 depicts the results. The results are representative for six independent blinded experiments.
Kinetic PCR for zfy1/zfy-2 Is a Reproducible Assay with Low Intra-Assay Variability
To determine the reproducibility of zfy1/zfy2 measurements, individual blood-derived male/female DNA mixtures (0.025%, 2.5%, and 50% male) were sequentially analyzed at four different time points over a two-week period. ACVof less than 1% was determined for Ct values of all samples combined tested (Table 1) . Kinetic PCR is a suitable and accurate strainindependent assay that can be used for a wide range of male/female DNA ratios. The simplicity and ability of high throughput will make it an attractive alternative to currently employed engraftment assays. If different biological processes are visualized simultaneously, then marker proteins with distinct spectral properties are required. Because GFP was first reported as an excellent marker for gene expression (4), considerable efforts have been applied to create different wavelength mutations of the wildtype GFP, thus enabling multicolor imaging. The use of a blue-shifted GFP variant (i.e., BFP) was suggested to complement GFP to facilitate two-color assessments of differential gene expression or protein trafficking (11) . To date, several GFP variants [e.g., the red-shifted S65T-mutants (6, 10, 12, 15, 21) ] that show brighter green fluorescence than wild-type GFP, and others such as cyan fluorescent protein (CFP), yellow fluorescent protein (YFP) (19) , enhanced cyan fluorescent protein (ECFP), and enhanced yellow fluorescent protein (EYFP), are used in molecular biology applications (3, 15) .
Recently, the palette of GFP-based fluorescent proteins has been enriched by the isolation of the gene of a red fluorescent protein (DsRed) from the nonbioluminescent coral Discosomasp. (16) . The crystal structure of the 28-kDa protein has been reported (23). DsRed differs considerably in its spectral properties from other fluorescent proteins, allowing for investigations that will use DsRed and other GFP variants in combination. The red fluorescent protein has an excitation peak at 558 nm and emits light with a maximum at 583 nm, far beyond the longest wavelength mutants of GFP (16, 22) . DsRed has been successfully expressed in prokaryotic cells, Xenopus laevis , and human embryonic kidney cells (16) . In its first technical application, different Pseudomonas fluorescens populations were labeled with three GFP variants and DsRed to visualize root colonization of tomato plants by these bacteria simultaneously (3). In addition, mixed E. coli cultures labeled with EGFP and DsRed were imaged by confocal, two-photon, and fluorescence lifetime microscopy to evaluate different excitation modes (12) . Further, DsRed1-1, a variant optimized for expression in mammalian and bacterial cells, was transiently expressed in Nicotiana benthamianacells (7) .
It has been reported that soluble-
